Objectif At Dr. Dolhay, our mission is to provide female hygiene and health products that serve the health of women and their sexual partners by use in the intimacy of the home.The iTampon project involves an innovative method – completely free of electronics – to diagnose female health at home. These two novel diagnostic devices will enable women to detect the sign of any infection, indicating the need to turn to a gynaecologist. Additional examinations can be carried out by sending samples to our laboratory partner.Early warning of potential diseases, such as cervical cancer or preterm birth, can save millions of lives, as women could undergo the necessary treatment in time. The project originates from a business development idea to internationally expand our current, market-leading product lines. However, the development has convinced two EU-based companies to offer us EU-wide cooperation, once the products are qualified to be launched on the market.The need for the products is well demonstrated, as it breaks through the key barrier women have against going to the gynaecologist: shyness and anxiety.We have developed two prototypes that are essential diagnostic tools at the level of consumer goods – keeping the intimacy of women using them:1) Intelligent Tampon Observer (iT Observer): it is a “pH meter” (“good flora indicator”) which provides a pH-status map of the whole vagina and cervix. 2) Intelligent Tampon Collector (iT Collector): it is a 2in1 solution, a “pH meter” and “home HPV/cancer test” which enables women to perform a basic gynecological self-examination in the privacy of their home. Champ scientifique engineering and technologymedical engineeringmedical laboratory technologymedical and health sciencesclinical medicineoncologycervical cancerengineering and technologymedical engineeringdiagnostic imagingmedical and health sciencesclinical medicinegynaecology Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.3. - Treating and managing disease Thème(s) PHC-12-2014-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices Appel à propositions H2020-SMEInst-2014-2015 Voir d’autres projets de cet appel Sous appel H2020-SMEINST-1-2014 Régime de financement SME-1 - SME instrument phase 1 Coordinateur DOLHAY KLINIKA EGESZSEGUGYI KFT Contribution nette de l'UE € 50 000,00 Adresse DOMOSZLO UTJA 18 1037 BUDAPEST Hongrie Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Közép-Magyarország Budapest Budapest Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 71 429,00
